Prot:I8F-MC-GPGM: Efficacy and Safety of Tirzepatide Once Weekly versus Insulin Glargine in Patients with Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)

Project: Research project

Project Details

StatusFinished
Effective start/end date4/12/19 → 4/12/22

Funding

  • Lilly USA, LLC (Prot:I8F-MC-GPGM)